ibutilide has been researched along with Acute Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Globits, S; Hirschl, MM; Wollmann, C | 1 |
Chaveles, JI; Dagadaki, OK; Kafkas, NV; Kelesidis, KM; Mertzanos, GA; Papageorgiou, KI; Patsilinakos, SP | 1 |
Califf, RM | 1 |
Mirzaietehrane, M; Sedighi, A; Varriale, P | 1 |
1 trial(s) available for ibutilide and Acute Disease
Article | Year |
---|---|
Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.
Topics: Acute Disease; Aged; Aged, 80 and over; Amiodarone; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Probability; Prospective Studies; Recurrence; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Sulfonamides; Treatment Outcome | 2007 |
3 other study(ies) available for ibutilide and Acute Disease
Article | Year |
---|---|
A 2-year survey of treatment of acute atrial fibrillation in an ED.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Diltiazem; Emergency Service, Hospital; Female; Flecainide; Humans; Male; Middle Aged; Sulfonamides; Time Factors; Treatment Outcome | 2011 |
What to do with acute atrial fibrillation?
Topics: Acute Disease; Anti-Arrhythmia Agents; Atrial Fibrillation; Confounding Factors, Epidemiologic; Humans; Sulfonamides | 1999 |
Ibutilide for termination of atrial fibrillation in the Wolff-Parkinson-White syndrome.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Electrocardiography; Female; Heart Conduction System; Heart Rate; Humans; Infusions, Intravenous; Sulfonamides; Wolff-Parkinson-White Syndrome | 1999 |